1994
DOI: 10.1128/iai.62.10.4626-4631.1994
|View full text |Cite
|
Sign up to set email alerts
|

Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D

Abstract: Mice (BALB/cJ, C3H/HeN, and C3HIHeJ) primed with actinomycin D became highly susceptible to lethal intoxication with staphylococcal enterotoxin B (SEB). The mice underwent toxicosis and toxic shock and died. Actinomycin D-primed C311/HeN and C3H/HeJ mice showed equal sensitivity to SEB, suggesting that bacterial lipopolysaccharide derived from gram-negative bacteria in the gut may not be an important cofactor in intoxication. In a time course study of the illness, prominent pathological changes characterized b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
11
0

Year Published

1996
1996
2015
2015

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(12 citation statements)
references
References 23 publications
1
11
0
Order By: Relevance
“…Upon considering the many Gramnegative bacteria that compose the intestinal flora, and increased numbers found in the vaginal flora of TSS patients, odds of this synergy naturally occurring are really quite high [164,165]. In concordance with human data, there is a good correlation between increased serum levels of IL-1, IL-2, TNF , and/or IFN with SEA-, SEB-, or TSST-1-induced shock in mice [148][149][150][151][152][153][154][155][156][157][158][159][160]. These efforts coincide with others involving SEA and genetic knockout mice deficient in IFN or the p55 receptor for TNF [141].…”
Section: Animal Models For Ses and Tsst-1: Necessary Steps Toward A Bmentioning
confidence: 52%
See 1 more Smart Citation
“…Upon considering the many Gramnegative bacteria that compose the intestinal flora, and increased numbers found in the vaginal flora of TSS patients, odds of this synergy naturally occurring are really quite high [164,165]. In concordance with human data, there is a good correlation between increased serum levels of IL-1, IL-2, TNF , and/or IFN with SEA-, SEB-, or TSST-1-induced shock in mice [148][149][150][151][152][153][154][155][156][157][158][159][160]. These efforts coincide with others involving SEA and genetic knockout mice deficient in IFN or the p55 receptor for TNF [141].…”
Section: Animal Models For Ses and Tsst-1: Necessary Steps Toward A Bmentioning
confidence: 52%
“…Mice are often used for obtaining a basic understanding of how toxins (and other biologically-active substances) interact in vivo, which includes the immunological mechanisms that promote superantigen-mediated shock [148][149][150][151][152][153][154][155][156]. Although these animals curiously lack an emetic response, they are cost-effectively ideal for in vivo screening of potential vaccines and therapeutics.…”
Section: Animal Models For Ses and Tsst-1: Necessary Steps Toward A Bmentioning
confidence: 99%
“…Primates respond to ingestion of SEB by vomiting, and intravenous or inhaled SEB can be fatal to them (5,41). Mice do not have a vomiting mechanism (5) and are insensitive to the lethal effects of injected SEB (53) unless they are pretreated in some way, such as with actinomycin D (14) or D-galactosamine (42). Therefore, the present study was undertaken to test whether CsA would protect monkeys against SEB intoxication, and to study the mechanism of protection.…”
Section: Introductionmentioning
confidence: 99%
“…Staphylococcus aureus causes many diseases in humans (6), and superantigens like the staphylococcal enterotoxins (SEs) plus toxic shock syndrome toxin 1 (TSST-1) are considered important virulence factors that induce immunosuppression in a host, thus providing a distinctly advantageous scenario for a pathogen (11,25). Current in vivo investigations with the SEs and TSST-1 have vigorously concentrated on murine models (9,20,28,32). Relative to the monkey emetic (36) or rabbit (7) models, mice afford an inexpensive alternative for studying (i) the in vivo effects of the SEs and TSST-1, (ii) neutralizing antibodies and therapeutics used against the SEs and TSST-1, and (iii) recombinantly attenuated SEs and TSST-1 used as vaccine candidates (1,32,33,39,40).…”
mentioning
confidence: 99%